Nasdaq1mon
Daré Bioscience Initiates Phase 3 Study for Sildenafil Cream as Potential First FDA-Approved Treatment for Female Sexual Arousal Disorder
Sildenafil Cream is a topical formulation ... feedback for safety and efficacy evaluations to support the indication of treatment of FSAD in premenopausal women. “We have appreciated the FDA ...
Yahoo Finance1mon
Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)
To date, there are no FDA-approved pharmacological treatments for FSAD; Daré’s Sildenafil Cream has the ... and efficacy evaluations to support the indication of treatment of FSAD in ...